PATENT CLAIM ANALYSIS

Application Number: 16059960
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "461000"]

Abstract:
Prodrugs of galiellactone, and derivatives thereof, are provided by reacting the parent compound, e.g. galiellactone, with a thiol. Such drugs may be administered orally to treat cancer and other proliferative diseases.

Claim (Index 25):
The compound according to  claim 18 , wherein R 2 , R 2 \u2032, R 3 , R 3 \u2032, R 4  and R 4 \u2032 are H.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.22581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15124096', '13811015', '15578589', '13202875', '12668599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8353959120581295
- 35 USC 102 Novelty (BERT): 0.6254942212702727
- Combined Prediction Score: 0.8144057429793439
- Mean Citation Score: 556.556944
- Max Citation Score: 727.63806
- Similarity Product: 487.3765144968653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test